Markers for predicting the development of acute respiratory distress syndrome

Annual Review of Medicine

Volumn 48, Issue , 1997, Pages 429-445

  Connelly, Kevin G ^a   Repine, John E ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Inflammation; Iron; Lipids; Neutrophils; Oxidants

Indexed keywords

CATALASE; FERRITIN; INTERLEUKIN 8; IRON; LIPID; MANGANESE SUPEROXIDE DISMUTASE; OXIDIZING AGENT;

ACUTE DISEASE; CLINICAL FEATURE; ENZYME BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INFLAMMATION; LUNG ENDOTHELIUM; LUNG INJURY; MALE; NEUTROPHIL; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SURVIVAL RATE;

EID: 0031048350     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.48.1.429     Document Type: Review

References (68)

1. Repine JE. 1992. Scientific perspectives on adult respiratory distress syndrome. Lancet 339:466-69
2. Ashbaugh DG, Bigelow DB, Petty TL, et al. 1967. Acute respiratory distress in adults. Lancet 2:319-23
3. Doyle RL, Szaflarski N, Modin GW, et al. 1995. Identification of patients with acute lung injury. Am. J. Respir. Crit. Care Med. 152:1818-24
4. Millberg JA, Davis DR, Steinberg KP, et al. 1995. Improved survival of patients with acute respiratory distress syndrome: 1983-93. JAMA 273:306-9
5. Pepe PE, Potkin RT, Revs DH, et al. 1982. Clinical predictors of the adult respiratory distress syndrome. Am. J. Surg. 144:124-30
6. Fowler AA, Hammon RF, Good JT. 1983. Adult respiratory distress syndrome: risk with common predisposition. Ann. Int. Med. 98:593-97
7. Hudson LD, Millierg JA, Anardi D. et al. 1995. Clinical risks for the development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151: 298-301
8. Mounder RI. 1985. Clinical prediction of the adult respiratory distress syndrome. Clin. Chest Med. 6:413-26
9. Jones KD. 1990. Markers for impending adult respiratory distress syndrome. Respir. Med. 84:89-91
10. Parsons PE, Moss M. 1996. Early detection and markers of sepsis. Clin. Chest Med. 17:199-212
11. Murray JF, Matthay MA, Luce JA, et al. 1988. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:720-23
12. Bernard GR, Artigas A, Brigham KL, et al. 1994. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149:818-24
13. Matuschak GM, Rinaldo JE, Pinsky MR, et al. 1987. Effect of end-stage liver failure of the incidence and resolution of the adult respiratory distress syndrome. J. Crit. Care 2:162-73
14. Moss M, Bucher B, Moore FA, et al. 1996. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 275:50-54
15. Fein AM, Lippmann M, Holtzman H, et al. 1983. The risk factors, incidence, and prognosis of ARDS following septicemia. Chest 83:40-42
16. Kaplan RL, Sahn SA, Petty TL. 1979. Incidence and outcome of the respiratory distress syndrome in gram-negative sepsis. Arch. Int. Med. 139:867-69
17. Carvalho ACA, Bellman SM, Saullo VJ, et al. 1982. Altered factor VIII in acute respiratory failure. N. Engl. J. Med. 307:1113-19
18. Thommasen HV, Boyko WI, Russell JA. 1984. Transient leucopenia associated with adult respiratory distress syndrome. Lancet 1:809-12
19. Weigelt JA, Snyder WH, Mitchell RA. 1981. Early identification of patients prone to develop adult respiratory distress syndrome. Am. J. Surg. 142:687-91
20. Pepe PE, Thomas RG, Stager MA, et al. 1983. Early prediction of the adult respiratory distress syndrome by a simple scoring method. Ann. Emerg. Med. 12:749-55
21. Donnelly TJ, Meade P, Jagels M, et al. 1994. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit. Care Med. 22:768-76
22. Roumen RMH, Redl H, Schlag G, et al. 1993. Scoring systems and blood lactate concentrations in relation to the development of adult respiratory distress syndrome and multiple organ failure in severely traumatized patients. J. Trauma 35:349-55
23. Tomashesfski JF, Davies P, Boggis C, et al. 1983. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am. J. Pathol. 112:112-26
24. Grant K, Rodvien R, Mielke CH. 1978. Altered factor VIII complexes in patients with acute respiratory insufficiency. Thromb. Haemost. 40:326-34
25. Rubin DB, Wiener-Kronish JP, Murray JF, et al. 1990. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J. Clin. Invest. 96:474-90
26. Moss M, Acherson L, Gillespie MK, et al. 1995. Von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151:15-20
27. Deleted in proof
28. Sabharwal AX, Bajaj SP, Ameri A, et al. 1996. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am. J. Respir. Crit. Care Med. 151:758-67
29. Rubin DB, Matthay MA, Weinberg PF, et al. 1985. Factor VIII antigen: possible plasma marker of progressive acute lung injury in patients with sepsis. Am. Rev. Respir. Dis. 131:A142 (Abstr.)
30. Hanley ME, Repine JE. 1994.Pathogenetic aspects of the adult respiratory distress syndrome. Semin. Resp. Med. 5:260-70
31. Rinaldo JE, Christman JW. 1990. Mechanisms and mediators of the adult respiratory distress syndrome. Clin. Chest Med. 11: 621-32
32. Craddock PR, Fehr J, Dalmasso AP, et al. 1977. Hemodialysis leukopenia. J. Clin. Invest. 59:879-88
33. Hammerschmidt DE, Hudson LD, Weaver IJ, et al. 1980. Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome. Lancet 1:947-49
34. Duchateau J, Haas M, Schreyen H, et al. 1984. Complement activation in patients at risk for developing the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 130:1058-64
35. Weinberg PF, Matthay MA, Webster RO, et al. 1984. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am. Rev. Respir. Dis. 130:791-96
36. Parsons PE, Worthen GS, Moore EE, et al. 1989. The association of circulating endotoxin with the development of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 140:294-301
37. Langlois PF, Gawvyl MS. 1988. Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:368-75
38. Parsons PE, Giclas PC. 1990. The terminal complement complex C5C5b-9 is not specifically associated with the development of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 141:98-103
39. Streeter RM, Kunkel SL. 1994. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J. Invest. Med. 4: 640-51
40. Chollet-Martin S, Rousset F, Chastre J, et al. 1994. Cytokines in adult respiratory distress syndrome. Lancet 344:1440 (Abstr.)
41. Parsons PE, Moore FA, Moore EE, et al. 1992. Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 146:694-700
42. Marks JD, Marks CB, Luce JM, et al. 1990. Plasma tumor necrosis factor in patients with septic shock. Am. Rev. Respir. Dis. 141:94-97
43. Roten R, Marken M, Feihl F, et al. 1991. Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 143:590-92
44. Hyers TW, Tricomi SM, Dettenmeier PA, et al. 1991. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 144:268-71
45. Suter PM, Suter S, Girardin E, et al. 1992. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am. Rev. Respir. Dis. 145:1016-22
46. Siler T, Swierkosz JE, Hyers TM, et al. 1989. Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp. Lung Res. 15: 881-94
47. Roumen RMH, Hendriks T, van der VenJongekrijg J, et al. 1993. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock and severe vascular trauma. Ann. Surg. 6:769-76
48. Donnelly JC, Streeter RM, Kunkel SL, et al. 1993. Interleukin-8 and development of adult respiratory distress syndrome in atrisk patient groups. Lancet 341:1356-60
49. 2 levels: correlation with the hemodynamic and pulmonary changes in grain negative septic shock. J. Lab. Clin. Med. 104:873-81
50. 4 and platelet activating factor. Crit. Care Med. 18:905-10
51. Ratnoff WD, Matthay NM, Wong MYS, et al. 1988. Sulfidopeptide-leukotriene peptidases in pulmonary edema fluid from patients with the adult respiratory distress syndrome. J. Clin. Immunol. 8:250-58
52. Matthay MA, Eschenbacher WL, Goetzl EJ. 1984. Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with adult respiratory distress syndrome. J. Clin. Immunol. 4:479-83
53. Stephenson AH, Lonisro AJ, Hyers TU, et al. 1988. Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at-risk for ARDS. Am. Rev. Respir. Dis. 138:714-19
54. Quinlan GJ, Lamb NJ, Evans TW, et al. 1996. Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. Crit. Care Med. 24:241-46
55. Bursten SL, Federighi DL, Harris WE, et al. 1996. Ratio of serum linoleate and oleate to palmitate predicts development of acute respiratory distress syndrome in patients with sepsis and trauma. Crit. Care Med. 24:1129-36
56. Tate RM, Repine JE. 1983. Neutrophils and the adult respiratory distress syndrome Am. Rev. Respir. Dis. 128:552-59
57. Wetland JE, Davis WB, Jolter JF, et al. 1986. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiological significance. Am. Rev. Respir. Dis. 133:218-25
58. Donnelly SC, MacGregor I, Zarnani A, et al. 1995. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151:1428-33
59. Donnelly SC, Haslett C, Dransfield I, et al. 1994. Role of selectins in development of adult respiratory distress syndrome. Lancet 344:215-19
60. Sakamaki F, Ishizako A, Handa M, et al. 1995. Soluble form of P-selectin in plasma is elevated in acute lung injury. Am. J. Respir. Crit. Care Med. 151:1821-26
61. Brigham KL. 1990. Oxidant stress and adult respiratory distress syndrome. Eur. Respir. J. 3:482-84
62. Roumen RMH, Henchiks T, deMan BM, et al. 1993. Serum lipofuscin as a pregnostic indicator of adult respiratory distress syndrome and multiple organ failure. Br. J. Surg. 81:1300-5
63. Leff JA, Parsons PE, Day CE, et al. 1993. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 341:777-80
64. Connally KG, Moss M, Parsons PE, et al. 1996. Serum ferritin as a predictor of the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153:A587(Abstr.); Am. J. Respir. Crit. Care Med. In press
65. Connally KG, Moss M, Parsons PE, et al. 1996. Serum ferritin as a predictor of the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153:A587(Abstr.); Am. J. Respir. Crit. Care Med. In press
66. Hyers TM. 1993. Prediction of survival and mortality in patients with adult respiratory distress syndrome. New Horizons 1:466-70
67. Clark JG, Auberg JA, Steinberg KP, et al. 1995. Type III precollagen peptide in the adult respiratory distress syndrome. Ann. Int. Med. 122:17-23
68. Meduri GM, Headley S, Kohler G, et al. 1995. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Chest 107:1062-73